Head and Neck Mucosal Melanoma — knowledge graph · CancerIndex

Knowledge graph · Cancer

Head and Neck Mucosal Melanoma

subtype

Identifier: CI-CAN-00000959
Entity page: /cancer/head-and-neck-mucosal-melanoma ↗
Edges: 14

Neighbours: 5 drugs9 trials
Drawn: 14 of 14 neighbours (cap 60); table lists every fetched edge

Accepted: cancer:<slug>, gene:<symbol>, variant:<slug>, drug:<slug>, trial:<NCT id>, or a bare CI id. Find slugs with search.

Most connectedLung Non-Small Cell Carcinoma 3,147 Malignant Colorectal Neoplasm 1,866 ABL1 298 EGFR 276 Imatinib 450 Dasatinib 321

Neighbourhood

Radial view

Focus at the centre; neighbours grouped by entity type. Click a node to re-centre the graph on it; ↗ opens the entity page. Hover a spoke for relationship, evidence level, cancer context and source.

Edges

Every edge, grouped by relationship

Source-native edges first (aggregated per neighbour, direction, evidence level and source), then derived registry links. Up to 15 per relationship (10 trials); “show all” raises one group to 200.

Relationship	Neighbour	Direction	Evidence level	Cancer context	Support	Claim	Source	Expand
Head and Neck Mucosal Melanoma investigated in trials for …INVESTIGATED_IN_TRIALSderived5 of 5
→ investigated in trials for	Nivolumabmonoclonal antibody 2 trials (1 active) · roll-up of the cancer and its descendants	—	—	Head and Neck Mucosal Melanoma	2	Observed	clinicaltrials	graph →
→ investigated in trials for	Pembrolizumabmonoclonal antibody 2 trials (1 active) · roll-up of the cancer and its descendants

Head and Neck Mucosal Melanoma studied in …STUDIED_INderived9 of 9
→ studied in	NCT05546827Phase 2 · recruiting Preoperative Radiotherapy and Immunotherapy for Sinonasal and Anorectal Mucosal Melanoma · condition mapped ALIAS · 9 trials mapped (4 active)	—	—	Sinonasal Mucosal Melanoma	1	Observed	clinicaltrials	graph →
→ studied in	NCT04318717Phase 2 · recruiting Pembrolizumab and Hypofractionated Radiation Therapy for the Treatment of Mucosal Melanoma · condition mapped ALIAS · 9 trials mapped (4 active)	—	—	Head and Neck Mucosal Melanoma	1	Observed	clinicaltrials	graph →
→ studied in	NCT05111574Phase 2 · active not recruiting Using Nivolumab Alone or With Cabozantinib to Prevent Mucosal Melanoma Return After Surgery · condition mapped ONTOLOGY_EXACT · 9 trials mapped (4 active)	—	—	Head and Neck Mucosal Melanoma	1	Observed	clinicaltrials	graph →
→ studied in	NCT07614828Phase 2 · withdrawn Exploratory Clinical Study of Neoadjuvant Immunotherapy Combined With Chemotherapy in Malignant Melanoma of Nasal and Paranasal Mucosa · condition mapped ALIAS · 9 trials mapped (4 active)	—	—	Head and Neck Mucosal Melanoma	1	Observed	clinicaltrials	graph →
→ studied in	NCT07662694not yet recruiting CLASSIFY-OMM: Multicenter Rare Disease Cohort for T-Stage Reclassification and Molecular Subtyping-Based Precision Therapy in Oral Mucosal Melanoma · condition mapped ALIAS · 9 trials mapped (4 active)	—	—	Head and Neck Mucosal Melanoma	1	Observed	clinicaltrials	graph →
→ studied in	NCT04879654Phase 2 · unknown Toripalimab Combined With Radiotherapy and Chemotherapy in the Treatment of SNMM After Endoscopic Surgery · condition mapped ALIAS · 9 trials mapped (4 active)	—	—	Sinonasal Mucosal Melanoma	1	Observed	clinicaltrials	graph →
→ studied in	NCT02748564Phase 2 · terminated Aldesleukin and Pembrolizumab in Treating Patients With Stage III-IV Melanoma · condition mapped CURATED_BROADER · 9 trials mapped (4 active)	—	—	Head and Neck Mucosal Melanoma	1	Observed	clinicaltrials	graph →
→ studied in	NCT05009446early Phase 1 · unknown Single Arm Study of Induction Chemoradiotherapy Combined With Surgery in the Treatment of Locally Advanced SNMM · condition mapped ALIAS · 9 trials mapped (4 active)	—	—	Sinonasal Mucosal Melanoma	1	Observed	clinicaltrials	graph →
→ studied in	NCT03220009Phase 2 · withdrawn Nivolumab or Expectant Observation Following Ipilimumab, Nivolumab, and Surgery in Treating Patients With High Risk Localized, Locoregionally Advanced, or Recurrent Mucosal Melanoma · condition mapped ALIAS · 9 trials mapped (4 active)	—	—	Head and Neck Mucosal Melanoma	1	Observed	clinicaltrials	graph →